Prostate Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Prostate Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
-
Narrated by:
-
By:
About this listen
Featuring perspectives from Dr Neeraj Agarwal, Dr Andrew J Armstrong, Dr Himisha Beltran, Dr Rana R McKay and Dr Fred Saad, moderated by Dr McKay, including the following topics:
- Introduction (0:00)
- Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Saad (2:12)
- Current Treatment for Metastatic HSPC — Dr Armstrong (26:12)
- Role of PARP Inhibition in Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Dr Agarwal (49:31)
- Current and Future Use of Radiopharmaceuticals for mCRPC — Dr McKay (1:12:51)
- Promising Novel Agents and Strategies Under Investigation for the Management of Prostate Cancer — Dr Beltran (1:36:11)
CME information and select publications
No reviews yet